Literature DB >> 31427776

Tick-TOX, it's time for T cell exhaustion.

Thomas H Mann1, Susan M Kaech2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31427776     DOI： 10.1038/s41590-019-0478-y

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  22 in total

1.  Hypoxia-inducible factor activity promotes antitumor effector function and tissue residency by CD8+ T cells.

Authors:  Ilkka Liikanen; Colette Lauhan; Sara Quon; Kyla Omilusik; Anthony T Phan; Laura Barceló Bartrolí; Amir Ferry; John Goulding; Joyce Chen; James P Scott-Browne; Jason T Yustein; Nicole E Scharping; Deborah A Witherden; Ananda W Goldrath
Journal:  J Clin Invest       Date:  2021-04-01       Impact factor: 14.808

2.  Interacting Genetic Lesions of Melanoma in the Tumor Microenvironment: Defining a Viable Therapy.

Authors:  R R Maniyar; S Chakraborty; T Jarboe; R Suriano; M Wallack; J Geliebter; R K Tiwari
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  CD8 memory precursor cell generation is a continuous process.

Authors:  Helena Todorov; Margaux Prieux; Daphne Laubreton; Matteo Bouvier; Shaoying Wang; Simon de Bernard; Christophe Arpin; Robrecht Cannoodt; Wouter Saelens; Arnaud Bonnaffoux; Olivier Gandrillon; Fabien Crauste; Yvan Saeys; Jacqueline Marvel
Journal:  iScience       Date:  2022-08-13

Review 4.  The TOX subfamily: all-round players in the immune system.

Authors:  Jiawen Han; Minjie Wan; Zhanchuan Ma; Ping He
Journal:  Clin Exp Immunol       Date:  2022-06-23       Impact factor: 5.732

5.  An activation to memory differentiation trajectory of tumor-infiltrating lymphocytes informs metastatic melanoma outcomes.

Authors:  Abhinav Jaiswal; Akanksha Verma; Ruth Dannenfelser; Marit Melssen; Itay Tirosh; Benjamin Izar; Tae-Gyun Kim; Christopher J Nirschl; K Sanjana P Devi; Walter C Olson; Craig L Slingluff; Victor H Engelhard; Levi Garraway; Aviv Regev; Kira Minkis; Charles H Yoon; Olga Troyanskaya; Olivier Elemento; Mayte Suárez-Fariñas; Niroshana Anandasabapathy
Journal:  Cancer Cell       Date:  2022-05-09       Impact factor: 38.585

Review 6.  Tumor-infiltrating lymphocytes in the immunotherapy era.

Authors:  Sterre T Paijens; Annegé Vledder; Marco de Bruyn; Hans W Nijman
Journal:  Cell Mol Immunol       Date:  2020-11-02       Impact factor: 11.530

7.  p16INK4a Regulates Cellular Senescence in PD-1-Expressing Human T Cells.

Authors:  Valérie Janelle; Mathieu Neault; Marie-Ève Lebel; Dave Maurice De Sousa; Salix Boulet; Ludovic Durrieu; Cédric Carli; Chloé Muzac; Sébastien Lemieux; Nathalie Labrecque; Heather J Melichar; Frédérick A Mallette; Jean-Sébastien Delisle
Journal:  Front Immunol       Date:  2021-08-09       Impact factor: 7.561

Review 8.  Gene Regulatory Circuits in Innate and Adaptive Immune Cells.

Authors:  Ankita Saini; Hazem E Ghoneim; Chan-Wang Jerry Lio; Patrick L Collins; Eugene M Oltz
Journal:  Annu Rev Immunol       Date:  2022-02-04       Impact factor: 32.481

9.  Persistent STAT5 activation reprograms the epigenetic landscape in CD4+ T cells to drive polyfunctionality and antitumor immunity.

Authors:  Zhi-Chun Ding; Huidong Shi; Nada S Aboelella; Kateryna Fesenkova; Eun-Jeong Park; Zhuoqi Liu; Lirong Pei; Jiaqi Li; Richard A McIndoe; Hongyan Xu; Gary A Piazza; Bruce R Blazar; David H Munn; Gang Zhou
Journal:  Sci Immunol       Date:  2020-10-30

10.  Increased frequency of TIGIT+CD73-CD8+ T cells with a TOX+ TCF-1low profile in patients with newly diagnosed and relapsed AML.

Authors:  F Brauneck; F Haag; R Woost; N Wildner; E Tolosa; A Rissiek; G Vohwinkel; J Wellbrock; C Bokemeyer; J Schulze Zur Wiesch; C Ackermann; W Fiedler
Journal:  Oncoimmunology       Date:  2021-06-21       Impact factor: 8.110
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.